Search tips
Search criteria 


Logo of mjafiGuide for AuthorsAbout this journalExplore this journalMedical Journal, Armed Forces India
Med J Armed Forces India. 1994 January; 50(1): 63–65.
Published online 2017 June 27. doi:  10.1016/S0377-1237(17)31042-0
PMCID: PMC5529699

WILSON'S DISEASE (A report of two cases)


Two cases of Wilson's disease are reported. First case presented with fulminant hepatic failure and had a fatal outcome. The second had an insiduous onset, neurological manifestations, and is progressing satisfactorily on zinc therapy. Problems in diagnosis and treatment are highlighted.

KEY WORDS: Wilson's disease, Fulminant hepatic failure, Zinc therapy


Wilson's disease is an autosomal recessive disorder characterised by degenerative changes in the brain, cirrhosis and Kayser – Fleischer rings in the cornea and was first described in 1912 [1]. It results from altered incorporation of coppper into hepatic proteins such as ceruloplasmin resulting in diffuse accumulation of copper in the cytosol of hepatocytes and later as liver cells are overloaded, copper is distributed to other tissues to which it is toxic. Its incidence is reported as 1 in 50,000–100,000 [2]. The gene concerned has been located on the chromosome region 13 q 14 [3]. Its presentation can be varied. The emphasis falls on different parts at different times. In children the liver is chiefly involved hence called hepatic form and as years advance, neuropsychiatric changes become increasingly important, so called nurological form [4].


A six and half year old Muslim boy born of a second degree consnnguinous marriage was admitted with severe epistaxis and abdominal distension for two days. There was no history of bleeding from any other site, trauma or bowel disturbance. No past history of jaundice, hematemesis, abdominal distension or a bleeding disorder. His scholastic performance was satisfactory. He was the youngest of four sibs, first two were healthy, the third sib had died at 0 years of age following severe epistaxis and mild jaundice with cause not known. Examination revealed a stuporous child with low grade fever, severe icterus, pedal oedema, a hepatomegaly of 3 cm with a sharp border and smooth surface, and splenomegaly of 3 cm with ascitis but no pallor. Slit lamp examination done once the child's condition improved revealed bilateral KF rings.

On investigation he had hemoglobin of 10.8 gm/dl with total and differential leucocyte counts within normal limits. The total serum bilirubin was 23.0 mg/dl direct – positive, SCOT – 112 IU/L, SGPT 22 IU/L, Alkaline hosphatase 4 KA units/100 ml (28.4 IU/L). Alkaline Phosphatase-total Bilirubin ratiol.2 and SGOT – SGPT ratio – 5. The prothrobin time was 2 min 9 sec as against 14 sec for the control. The HBsAg was negative. Copper studies could not be carried out due to lack of facilities and patients condition not permitting a move. He was managed conservatively with blood transfusions, antibiotics and bowel wash. D-penicillamine was started in a dose of 250 mg twice a day. Child showed marginal improvement but within a month developed hepatic encephalopathy and succumbed to his illness.

Parents and other sibs had no heptomegaly or KF rings and their liver function tests were normal. Copper studios for the sibs have been advised.


Fifteen years old Hindu girl born of a 2nd degree nonsanguinous marriage presented to the OPD with deteriorating school perfomance and increasing lethargy noted over two years. Three previous sibs had died at six, eight and seven years of age with jaundice and abdominal distension but the casue was not known. The girl gave no history of jaundice, involuntary movements or speech disorder. Examination revealed bilateral Kayser — Fleischer rings but no other abnormality.

On investigation, her liver functions were within normal limits, serum and urinary copper studies carried out in Delhi for the patient and family members were as given in Table 1. No KF rings were seen in any other member of the family. She was treated with D-Penicillaminc 500 mg twice a day for six months with improvement in her scholastic performance. Presently she is on zinc therapy for the past one year with Cap Zevit (61.8 mg zinc) 1 TDS and has shown no deterioration.

Serum and Urinary Coppper Studies


In a review of 51 consecutive patients with Wilson's disease the mean ago for initial symptoms was 15.5 yrs [5], Our first case presented with fulminant Wilson's disease at six and a half years. In a case of cirrhosis, the liver usually has an uneven surface. In our patient, the liver was smooth probably due to its hepatitis like presentation. The disease may appear as early as the fourth or fifth year of life as acute or chronic heatitis and pursue a relentless course to liver failure [6]. Establishing a diagnosis of fulminant Wilson's disease can be difficult specially when facilities for copper studies are not available. A setting of consanguinous marriage, death of a sib with similar ailment and clinical features of hepatocelluar failure lead to a high index of suspicion. Bilateral KF rings seen under slit lamp examination confirmed this suspicion. The alkaline phosphatase-total bilirubin ratio was 1.2 and SGOT – SGPT ratio was 5.0. Cut off values of less than 2.0 for the former and greater than 4.0 for the latter are associated with a diagnosis of fulminant hepatic failure caused by Wilson's disease [7]. Tests of copper metabolism, including serum and urinary copper, and serum ceruloplasmin levels may not always be abnormal and facilities for their evaluation may not be available. When available the following abnormalities are of major diagnostic value in patients with Wilson's disease: Serum ceruloplasmin below 10 mg/dl, tissue copper above 25 mg/100 gm of dry weight of liver and a characteristic lack of incorporation of radio-labelled copper into ceruloplasmin followingoral or intravenous administration [8]. KF rings may be missed unless looked for under slit lamp examination.

Though D-penicillamine was started, the child succumbed to his illness. The only effective treatment for fulminant Wilson's disease seems to be liver transplantation [9]. The second case posed no diagnostic dilemma. D-penicillamine the conventionally used copper chelating agent for treatment of Wilson's disease is costly and difficult to procure in smaller cities. Zinc therapy appears to be a reasonable option for the initial [10,11] as well as maintenance therapy in Wilson's disease [12]. Sibling and parent screening for early diagnosis and genetic counselling is a must. Noninvasive screening approaches like KF rings, elevated liver enzymes, elevated urine copper or elevated plasma nonceruloplasmin copper are not adequate to identify all asymptomatic cases of Wilson's disease. Symptom free homozygotes will usually have serum ceruloplasmin below 20 mg/dl and liver biopsy for copper content would reveal values above 25 mg/100 gm dry weight [4]. Recently molecular genetics for sibling screening of affected patients has been described using a probe from the linked retinoblastoma gene [13].


1. Marsden CD. Wilson's disnaso. Quart J Med. 1987;65:959–966. [PubMed]
2. William F. Ratistreri. Wilson Disease. In: Behrman RF, Vaughan VC, editors. Nelson Textbook of Pediatrics, 13h edn. WB Saunders Co; Philadelphia: 1987. pp. 836–837.
3. Danks DM. Copper and liver disease. Eer J Pediatr. 1991;159:142–148. [PubMed]
4. Sheila Sherlock. Disease of the Liver and Biliary System. 6th Edn. Oxford : Blackwell Scientific Publications. 1975:477–487.
5. Strummel W, Meyerrose KW, Niederau C, Hofter H, Keuzpaintner G, Strohmeyer C. Wilson's disease; Clinical Presentation, treatment and survival. Ann Inter Med. 1991;115:720–730.
6. Cotran RS. Vinay Kumar: Robbins SL. Robbins Pathologic Rosis of Disease 4th Edition. London : UB Sounders Company. 1909:956–997.
7. Berman DH, Leventhal RI. Gavaler JS, Cadoff EM Van Thiol DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology. 1991;100:1129–1134. [PubMed]
8. Irmin Sternlieb. Laboratory diagnosis of hepatolenticular degeneration. In: Surderman FW, Sunderman FW Jr, editors. Diagnosis of liver disorders, 1st Edn. Warrin H Green Inc; USA: 1968. pp. 189–192.
9. Stampfl DA, Munoz SJ, Moritz MJ, Ruben R, Armenti VT, Jarrell BE, Maddrey WC. Heterotopic liver transplantation for fulminant Wilson's disease. Gastroenterology. 1990;90:1834–1836. [PubMed]
10. Brewer GJ, Yazbasiyan Gukan V, Lee DY, Appleman H. Treatment of Wilson's disease, with zinc : Initial treatment studies. J Lab Clin Med. 1989;114:633–638. [PubMed]
11. Milanino R, Marrella M, Moretti U, Velo GP, Degenello A, Ribezzo G, Tato L. Oral zinc sulphate as primary therapeutic intervention in a child with Wilson's disease. Eur J Pediatr. 1989;148:654–655. [PubMed]
12. Mayel IV. Low dose zinc therapy for maintenance treatment of Wilson's disease. Clin Pharma. 1990;9:951–953. [PubMed]
13. Yuzbasiyan – Gurkan V, Johnson V, Brewar GJ. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis. J Lab Clin Med. 1991;118:458–465. [PubMed]

Articles from Medical Journal, Armed Forces India are provided here courtesy of Elsevier